Barry Quart
Direttore/Membro del Consiglio presso KINIKSA PHARMACEUTICALS, LTD.
Patrimonio netto: 541 922 $ in data 30/04/2024
Profilo
Barry D.
Quart was the founder of Ardea Biosciences, Inc. founded in 2006, where he held the title of President, Chief Executive Officer & Director from 2012 to 2013.
Currently, he is a Director at NeuroGenetic Pharmaceuticals, Inc., an Independent Director at Kiniksa Pharmaceuticals Ltd.
since 2015, and a Director at Kiniksa Pharmaceuticals Corp.
He was the Chairman & Chief Executive Officer at Heron Therapeutics, Inc. from 2020 to 2023, and a Director at Trimeris, Inc. from 2007 to 2011.
He held the title of Director, SVP-Global Research & Development at Pfizer (La Jolla), and was an Independent Director at Synageva BioPharma Corp.
from 2012 to 2015.
He was also the President-Research & Development at Agouron Pharmaceuticals LLC, and Senior VP-Pfizer Global Research & Development at Pfizer Inc. He founded Napo Pharmaceuticals, Inc. in 2002, where he held the title of President until 2006.
Dr. Quart holds a doctorate degree from The University of California, San Francisco.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
HERON THERAPEUTICS INC
0.12% | 31/03/2024 | 177 989 ( 0.12% ) | 453 872 $ | 30/04/2024 |
| 15/04/2024 | 5 000 ( 0.01% ) | 88 050 $ | 30/04/2024 |
Posizioni attive di Barry Quart
| Società | Posizione | Inizio |
|---|---|---|
| KINIKSA PHARMACEUTICALS, LTD. | Direttore/Membro del Consiglio | 01/10/2015 |
NeuroGenetic Pharmaceuticals, Inc.
 NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroGenetic Pharmaceuticals, Inc. discovers and develops drugs for the prevention of neurodegenerative conditions. The company was founded by William T. Comer, Rudy Tanzi and Steven L. Wagner in 2009 and is headquartered in Del Mar, CA. | Direttore/Membro del Consiglio | - |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Barry Quart
| Società | Posizione | Fine |
|---|---|---|
| HERON THERAPEUTICS, INC. | Amministratore Delegato | 03/04/2023 |
| SYNAGEVA BIOPHARMA CORP | Direttore/Membro del Consiglio | 22/06/2015 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Fondatore | 01/05/2013 |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Direttore/Membro del Consiglio | 04/11/2011 |
Napo Pharmaceuticals, Inc.
 Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA. | Presidente | 01/12/2006 |
Formazione di Barry Quart
| The University of California, San Francisco | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| Aziende private | 8 |
|---|---|
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA. | Health Technology |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer (La Jolla) is a company that provides research services. The company is based in San Diego, CA. The company was founded by Michael R. Jirousek. | Commercial Services |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroGenetic Pharmaceuticals, Inc. discovers and develops drugs for the prevention of neurodegenerative conditions. The company was founded by William T. Comer, Rudy Tanzi and Steven L. Wagner in 2009 and is headquartered in Del Mar, CA. | Health Technology |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Health Technology |
- Borsa valori
- Insiders
- Barry Quart
